Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00281580 · ClinicalTrials.gov registry record · Phase 3
Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension
A Phase 3 study, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,461
- Enrollment target
NCT00281580 is a Phase 3 study that has completed, run by Boehringer Ingelheim. The registered enrollment target is 1,461 participants.
The verdict
NCT00281580, a Phase 3 study, has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,461 participants
- Enrollment target
Study Summary
To demonstrate that Micardis and Norvasc when used together are more effective at lowering blood pre ssure.
Interventions
- DRUG Placebo
- DRUG Amlodipine 5 mg
- DRUG Telmisartan 20 mg
- DRUG Telmisartan 40 mg
- DRUG Amlodipine 10 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,461 participants |
| Start Date | 2006-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00281580
The ClinicalTrials.gov registry entry for NCT00281580 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,461 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boehringer Ingelheim, which has 515 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT00281580 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00281580 about?
NCT00281580 is a clinical study titled "Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension". To demonstrate that Micardis and Norvasc when used together are more effective at lowering blood pre ssure.
What is the current status of trial NCT00281580?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,461 participants. The study started on 2006-04.
What interventions are being tested in trial NCT00281580?
The interventions under investigation include: Placebo (DRUG), Amlodipine 5 mg (DRUG), Telmisartan 20 mg (DRUG), Telmisartan 40 mg (DRUG), Amlodipine 10 mg (DRUG).
Who is sponsoring clinical trial NCT00281580?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.